secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vanda Pharmaceuticals Inc. (VNDA)
CIK:        0001347178
Form:       8-K
Filed at:   2025-01-27T23:59:59+00:00
Accession:  0001193125-25-012740
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Vanda files NDA for tradipitant to treat motion sickness
--------------------------------------------------------

- Vanda disclosed via 8-K that it filed a New Drug Application for tradipitant for motion sickness.
- Announcement made via social media post on X on January 25, 2025, referencing WWII context.
- No approval or timeline provided; filing is a regulatory step toward potential commercialization.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347178/000119312525012740/0001193125-25-012740-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347178/000119312525012740/d869105d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-012740

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer